Global Inactivated Influenza Vaccine Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Inactivated Influenza Vaccine market size was estimated at USD 8151.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Influenza Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Influenza Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Influenza Vaccine market.
Global Inactivated Influenza Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
Children
Adolescence
Adults
Elderly
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Inactivated Influenza Vaccine Market
Overview of the regional outlook of the Inactivated Influenza Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Influenza Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Inactivated Influenza Vaccine market size was estimated at USD 8151.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Influenza Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Influenza Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Influenza Vaccine market.
Global Inactivated Influenza Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
Children
Adolescence
Adults
Elderly
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Inactivated Influenza Vaccine Market
Overview of the regional outlook of the Inactivated Influenza Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Influenza Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inactivated Influenza Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Vaccine Segment by Type
1.2.2 Inactivated Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inactivated Influenza Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Influenza Vaccine Product Life Cycle
3.3 Global Inactivated Influenza Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Influenza Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Influenza Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Influenza Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Influenza Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Influenza Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Influenza Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED INFLUENZA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Influenza Vaccine Market Size by Type (2020-2025)
6.4 Global Inactivated Influenza Vaccine Price by Type (2020-2025)
7 INACTIVATED INFLUENZA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Influenza Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED INFLUENZA VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Vaccine Sales Market Share by Region
8.2 Global Inactivated Influenza Vaccine Market Size by Region
8.2.1 Global Inactivated Influenza Vaccine Market Size by Region
8.2.2 Global Inactivated Influenza Vaccine Market Size by Region
8.3 North America
8.3.1 North America Inactivated Influenza Vaccine Sales by Country
8.3.2 North America Inactivated Influenza Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Influenza Vaccine Sales by Country
8.4.2 Europe Inactivated Influenza Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Influenza Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Influenza Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Influenza Vaccine Sales by Country
8.6.2 South America Inactivated Influenza Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Influenza Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Influenza Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED INFLUENZA VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Influenza Vaccine by Region(2020-2025)
9.2 Global Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Influenza Vaccine Production
9.4.1 North America Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Influenza Vaccine Production
9.5.1 Europe Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Influenza Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Influenza Vaccine Production (2020-2025)
9.7.1 China Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Limited
10.1.1 CSL Limited Basic Information
10.1.2 CSL Limited Inactivated Influenza Vaccine Product Overview
10.1.3 CSL Limited Inactivated Influenza Vaccine Product Market Performance
10.1.4 CSL Limited Business Overview
10.1.5 CSL Limited SWOT Analysis
10.1.6 CSL Limited Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Influenza Vaccine Product Overview
10.2.3 GSK Inactivated Influenza Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
10.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Inactivated Influenza Vaccine Product Overview
10.4.3 Viatris Inactivated Influenza Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 Hualan Biological
10.5.1 Hualan Biological Basic Information
10.5.2 Hualan Biological Inactivated Influenza Vaccine Product Overview
10.5.3 Hualan Biological Inactivated Influenza Vaccine Product Market Performance
10.5.4 Hualan Biological Business Overview
10.5.5 Hualan Biological Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Basic Information
10.6.2 AstraZeneca Inactivated Influenza Vaccine Product Overview
10.6.3 AstraZeneca Inactivated Influenza Vaccine Product Market Performance
10.6.4 AstraZeneca Business Overview
10.6.5 AstraZeneca Recent Developments
10.7 Sinovac Biotech
10.7.1 Sinovac Biotech Basic Information
10.7.2 Sinovac Biotech Inactivated Influenza Vaccine Product Overview
10.7.3 Sinovac Biotech Inactivated Influenza Vaccine Product Market Performance
10.7.4 Sinovac Biotech Business Overview
10.7.5 Sinovac Biotech Recent Developments
10.8 Aleph Biomedical
10.8.1 Aleph Biomedical Basic Information
10.8.2 Aleph Biomedical Inactivated Influenza Vaccine Product Overview
10.8.3 Aleph Biomedical Inactivated Influenza Vaccine Product Market Performance
10.8.4 Aleph Biomedical Business Overview
10.8.5 Aleph Biomedical Recent Developments
10.9 Abbott Laboratories
10.9.1 Abbott Laboratories Basic Information
10.9.2 Abbott Laboratories Inactivated Influenza Vaccine Product Overview
10.9.3 Abbott Laboratories Inactivated Influenza Vaccine Product Market Performance
10.9.4 Abbott Laboratories Business Overview
10.9.5 Abbott Laboratories Recent Developments
10.10 Novartis International
10.10.1 Novartis International Basic Information
10.10.2 Novartis International Inactivated Influenza Vaccine Product Overview
10.10.3 Novartis International Inactivated Influenza Vaccine Product Market Performance
10.10.4 Novartis International Business Overview
10.10.5 Novartis International Recent Developments
10.11 Changchun Institute of Biological
10.11.1 Changchun Institute of Biological Basic Information
10.11.2 Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
10.11.3 Changchun Institute of Biological Inactivated Influenza Vaccine Product Market Performance
10.11.4 Changchun Institute of Biological Business Overview
10.11.5 Changchun Institute of Biological Recent Developments
10.12 BCHT
10.12.1 BCHT Basic Information
10.12.2 BCHT Inactivated Influenza Vaccine Product Overview
10.12.3 BCHT Inactivated Influenza Vaccine Product Market Performance
10.12.4 BCHT Business Overview
10.12.5 BCHT Recent Developments
10.13 Jiangsu GDK
10.13.1 Jiangsu GDK Basic Information
10.13.2 Jiangsu GDK Inactivated Influenza Vaccine Product Overview
10.13.3 Jiangsu GDK Inactivated Influenza Vaccine Product Market Performance
10.13.4 Jiangsu GDK Business Overview
10.13.5 Jiangsu GDK Recent Developments
10.14 KM Biologics
10.14.1 KM Biologics Basic Information
10.14.2 KM Biologics Inactivated Influenza Vaccine Product Overview
10.14.3 KM Biologics Inactivated Influenza Vaccine Product Market Performance
10.14.4 KM Biologics Business Overview
10.14.5 KM Biologics Recent Developments
11 INACTIVATED INFLUENZA VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Influenza Vaccine Market Size Forecast
11.2 Global Inactivated Influenza Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Influenza Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Influenza Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Influenza Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inactivated Influenza Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Type (2026-2035)
12.1.2 Global Inactivated Influenza Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inactivated Influenza Vaccine by Type (2026-2035)
12.2 Global Inactivated Influenza Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Inactivated Influenza Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Influenza Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inactivated Influenza Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Vaccine Segment by Type
1.2.2 Inactivated Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inactivated Influenza Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Influenza Vaccine Product Life Cycle
3.3 Global Inactivated Influenza Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Influenza Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Influenza Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Influenza Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Influenza Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Influenza Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Influenza Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED INFLUENZA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Influenza Vaccine Market Size by Type (2020-2025)
6.4 Global Inactivated Influenza Vaccine Price by Type (2020-2025)
7 INACTIVATED INFLUENZA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Influenza Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED INFLUENZA VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Vaccine Sales Market Share by Region
8.2 Global Inactivated Influenza Vaccine Market Size by Region
8.2.1 Global Inactivated Influenza Vaccine Market Size by Region
8.2.2 Global Inactivated Influenza Vaccine Market Size by Region
8.3 North America
8.3.1 North America Inactivated Influenza Vaccine Sales by Country
8.3.2 North America Inactivated Influenza Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Influenza Vaccine Sales by Country
8.4.2 Europe Inactivated Influenza Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Influenza Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Influenza Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Influenza Vaccine Sales by Country
8.6.2 South America Inactivated Influenza Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Influenza Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Influenza Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED INFLUENZA VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Influenza Vaccine by Region(2020-2025)
9.2 Global Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Influenza Vaccine Production
9.4.1 North America Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Influenza Vaccine Production
9.5.1 Europe Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Influenza Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Influenza Vaccine Production (2020-2025)
9.7.1 China Inactivated Influenza Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Limited
10.1.1 CSL Limited Basic Information
10.1.2 CSL Limited Inactivated Influenza Vaccine Product Overview
10.1.3 CSL Limited Inactivated Influenza Vaccine Product Market Performance
10.1.4 CSL Limited Business Overview
10.1.5 CSL Limited SWOT Analysis
10.1.6 CSL Limited Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Influenza Vaccine Product Overview
10.2.3 GSK Inactivated Influenza Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
10.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Inactivated Influenza Vaccine Product Overview
10.4.3 Viatris Inactivated Influenza Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 Hualan Biological
10.5.1 Hualan Biological Basic Information
10.5.2 Hualan Biological Inactivated Influenza Vaccine Product Overview
10.5.3 Hualan Biological Inactivated Influenza Vaccine Product Market Performance
10.5.4 Hualan Biological Business Overview
10.5.5 Hualan Biological Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Basic Information
10.6.2 AstraZeneca Inactivated Influenza Vaccine Product Overview
10.6.3 AstraZeneca Inactivated Influenza Vaccine Product Market Performance
10.6.4 AstraZeneca Business Overview
10.6.5 AstraZeneca Recent Developments
10.7 Sinovac Biotech
10.7.1 Sinovac Biotech Basic Information
10.7.2 Sinovac Biotech Inactivated Influenza Vaccine Product Overview
10.7.3 Sinovac Biotech Inactivated Influenza Vaccine Product Market Performance
10.7.4 Sinovac Biotech Business Overview
10.7.5 Sinovac Biotech Recent Developments
10.8 Aleph Biomedical
10.8.1 Aleph Biomedical Basic Information
10.8.2 Aleph Biomedical Inactivated Influenza Vaccine Product Overview
10.8.3 Aleph Biomedical Inactivated Influenza Vaccine Product Market Performance
10.8.4 Aleph Biomedical Business Overview
10.8.5 Aleph Biomedical Recent Developments
10.9 Abbott Laboratories
10.9.1 Abbott Laboratories Basic Information
10.9.2 Abbott Laboratories Inactivated Influenza Vaccine Product Overview
10.9.3 Abbott Laboratories Inactivated Influenza Vaccine Product Market Performance
10.9.4 Abbott Laboratories Business Overview
10.9.5 Abbott Laboratories Recent Developments
10.10 Novartis International
10.10.1 Novartis International Basic Information
10.10.2 Novartis International Inactivated Influenza Vaccine Product Overview
10.10.3 Novartis International Inactivated Influenza Vaccine Product Market Performance
10.10.4 Novartis International Business Overview
10.10.5 Novartis International Recent Developments
10.11 Changchun Institute of Biological
10.11.1 Changchun Institute of Biological Basic Information
10.11.2 Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
10.11.3 Changchun Institute of Biological Inactivated Influenza Vaccine Product Market Performance
10.11.4 Changchun Institute of Biological Business Overview
10.11.5 Changchun Institute of Biological Recent Developments
10.12 BCHT
10.12.1 BCHT Basic Information
10.12.2 BCHT Inactivated Influenza Vaccine Product Overview
10.12.3 BCHT Inactivated Influenza Vaccine Product Market Performance
10.12.4 BCHT Business Overview
10.12.5 BCHT Recent Developments
10.13 Jiangsu GDK
10.13.1 Jiangsu GDK Basic Information
10.13.2 Jiangsu GDK Inactivated Influenza Vaccine Product Overview
10.13.3 Jiangsu GDK Inactivated Influenza Vaccine Product Market Performance
10.13.4 Jiangsu GDK Business Overview
10.13.5 Jiangsu GDK Recent Developments
10.14 KM Biologics
10.14.1 KM Biologics Basic Information
10.14.2 KM Biologics Inactivated Influenza Vaccine Product Overview
10.14.3 KM Biologics Inactivated Influenza Vaccine Product Market Performance
10.14.4 KM Biologics Business Overview
10.14.5 KM Biologics Recent Developments
11 INACTIVATED INFLUENZA VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Influenza Vaccine Market Size Forecast
11.2 Global Inactivated Influenza Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Influenza Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Influenza Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Influenza Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inactivated Influenza Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Type (2026-2035)
12.1.2 Global Inactivated Influenza Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inactivated Influenza Vaccine by Type (2026-2035)
12.2 Global Inactivated Influenza Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Inactivated Influenza Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Influenza Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inactivated Influenza Vaccine Market Size by Type (M USD)
Table 4. Global Inactivated Influenza Vaccine Market Size by Application
Table 5. Inactivated Influenza Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Inactivated Influenza Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inactivated Influenza Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2025)
Table 11. Global Market Inactivated Influenza Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inactivated Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Influenza Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inactivated Influenza Vaccine Sales by Type (K MT)
Table 27. Global Inactivated Influenza Vaccine Market Size by Type (M USD)
Table 28. Global Inactivated Influenza Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Inactivated Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Inactivated Influenza Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Inactivated Influenza Vaccine Market Share by Type (2020-2025)
Table 32. Global Inactivated Influenza Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Inactivated Influenza Vaccine Sales (K MT) by Application
Table 34. Global Inactivated Influenza Vaccine Market Size by Application
Table 35. Global Inactivated Influenza Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Inactivated Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Inactivated Influenza Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inactivated Influenza Vaccine Market Share by Application (2020-2025)
Table 39. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Inactivated Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025)
Table 44. North America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inactivated Influenza Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Limited Basic Information
Table 63. CSL Limited Inactivated Influenza Vaccine Product Overview
Table 64. CSL Limited Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Limited Business Overview
Table 66. CSL Limited SWOT Analysis
Table 67. CSL Limited Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Inactivated Influenza Vaccine Product Overview
Table 70. GSK Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Sanofi Pasteur Basic Information
Table 75. Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
Table 76. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Pasteur Business Overview
Table 78. Sanofi Pasteur SWOT Analysis
Table 79. Sanofi Pasteur Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Inactivated Influenza Vaccine Product Overview
Table 82. Viatris Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. Hualan Biological Basic Information
Table 86. Hualan Biological Inactivated Influenza Vaccine Product Overview
Table 87. Hualan Biological Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Hualan Biological Business Overview
Table 89. Hualan Biological Recent Developments
Table 90. AstraZeneca Basic Information
Table 91. AstraZeneca Inactivated Influenza Vaccine Product Overview
Table 92. AstraZeneca Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Recent Developments
Table 95. Sinovac Biotech Basic Information
Table 96. Sinovac Biotech Inactivated Influenza Vaccine Product Overview
Table 97. Sinovac Biotech Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sinovac Biotech Business Overview
Table 99. Sinovac Biotech Recent Developments
Table 100. Aleph Biomedical Basic Information
Table 101. Aleph Biomedical Inactivated Influenza Vaccine Product Overview
Table 102. Aleph Biomedical Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Aleph Biomedical Business Overview
Table 104. Aleph Biomedical Recent Developments
Table 105. Abbott Laboratories Basic Information
Table 106. Abbott Laboratories Inactivated Influenza Vaccine Product Overview
Table 107. Abbott Laboratories Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Abbott Laboratories Business Overview
Table 109. Abbott Laboratories Recent Developments
Table 110. Novartis International Basic Information
Table 111. Novartis International Inactivated Influenza Vaccine Product Overview
Table 112. Novartis International Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Novartis International Business Overview
Table 114. Novartis International Recent Developments
Table 115. Changchun Institute of Biological Basic Information
Table 116. Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
Table 117. Changchun Institute of Biological Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Changchun Institute of Biological Business Overview
Table 119. Changchun Institute of Biological Recent Developments
Table 120. BCHT Basic Information
Table 121. BCHT Inactivated Influenza Vaccine Product Overview
Table 122. BCHT Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. BCHT Business Overview
Table 124. BCHT Recent Developments
Table 125. Jiangsu GDK Basic Information
Table 126. Jiangsu GDK Inactivated Influenza Vaccine Product Overview
Table 127. Jiangsu GDK Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jiangsu GDK Business Overview
Table 129. Jiangsu GDK Recent Developments
Table 130. KM Biologics Basic Information
Table 131. KM Biologics Inactivated Influenza Vaccine Product Overview
Table 132. KM Biologics Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. KM Biologics Business Overview
Table 134. KM Biologics Recent Developments
Table 135. Global Inactivated Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Inactivated Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Inactivated Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Inactivated Influenza Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Inactivated Influenza Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Inactivated Influenza Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Inactivated Influenza Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Inactivated Influenza Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inactivated Influenza Vaccine Market Size by Type (M USD)
Table 4. Global Inactivated Influenza Vaccine Market Size by Application
Table 5. Inactivated Influenza Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Inactivated Influenza Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inactivated Influenza Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2025)
Table 11. Global Market Inactivated Influenza Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inactivated Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Influenza Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inactivated Influenza Vaccine Sales by Type (K MT)
Table 27. Global Inactivated Influenza Vaccine Market Size by Type (M USD)
Table 28. Global Inactivated Influenza Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Inactivated Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Inactivated Influenza Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Inactivated Influenza Vaccine Market Share by Type (2020-2025)
Table 32. Global Inactivated Influenza Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Inactivated Influenza Vaccine Sales (K MT) by Application
Table 34. Global Inactivated Influenza Vaccine Market Size by Application
Table 35. Global Inactivated Influenza Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Inactivated Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Inactivated Influenza Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inactivated Influenza Vaccine Market Share by Application (2020-2025)
Table 39. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Inactivated Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025)
Table 44. North America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inactivated Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Inactivated Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inactivated Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inactivated Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inactivated Influenza Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inactivated Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Limited Basic Information
Table 63. CSL Limited Inactivated Influenza Vaccine Product Overview
Table 64. CSL Limited Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Limited Business Overview
Table 66. CSL Limited SWOT Analysis
Table 67. CSL Limited Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Inactivated Influenza Vaccine Product Overview
Table 70. GSK Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Sanofi Pasteur Basic Information
Table 75. Sanofi Pasteur Inactivated Influenza Vaccine Product Overview
Table 76. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Pasteur Business Overview
Table 78. Sanofi Pasteur SWOT Analysis
Table 79. Sanofi Pasteur Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Inactivated Influenza Vaccine Product Overview
Table 82. Viatris Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. Hualan Biological Basic Information
Table 86. Hualan Biological Inactivated Influenza Vaccine Product Overview
Table 87. Hualan Biological Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Hualan Biological Business Overview
Table 89. Hualan Biological Recent Developments
Table 90. AstraZeneca Basic Information
Table 91. AstraZeneca Inactivated Influenza Vaccine Product Overview
Table 92. AstraZeneca Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Recent Developments
Table 95. Sinovac Biotech Basic Information
Table 96. Sinovac Biotech Inactivated Influenza Vaccine Product Overview
Table 97. Sinovac Biotech Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sinovac Biotech Business Overview
Table 99. Sinovac Biotech Recent Developments
Table 100. Aleph Biomedical Basic Information
Table 101. Aleph Biomedical Inactivated Influenza Vaccine Product Overview
Table 102. Aleph Biomedical Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Aleph Biomedical Business Overview
Table 104. Aleph Biomedical Recent Developments
Table 105. Abbott Laboratories Basic Information
Table 106. Abbott Laboratories Inactivated Influenza Vaccine Product Overview
Table 107. Abbott Laboratories Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Abbott Laboratories Business Overview
Table 109. Abbott Laboratories Recent Developments
Table 110. Novartis International Basic Information
Table 111. Novartis International Inactivated Influenza Vaccine Product Overview
Table 112. Novartis International Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Novartis International Business Overview
Table 114. Novartis International Recent Developments
Table 115. Changchun Institute of Biological Basic Information
Table 116. Changchun Institute of Biological Inactivated Influenza Vaccine Product Overview
Table 117. Changchun Institute of Biological Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Changchun Institute of Biological Business Overview
Table 119. Changchun Institute of Biological Recent Developments
Table 120. BCHT Basic Information
Table 121. BCHT Inactivated Influenza Vaccine Product Overview
Table 122. BCHT Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. BCHT Business Overview
Table 124. BCHT Recent Developments
Table 125. Jiangsu GDK Basic Information
Table 126. Jiangsu GDK Inactivated Influenza Vaccine Product Overview
Table 127. Jiangsu GDK Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jiangsu GDK Business Overview
Table 129. Jiangsu GDK Recent Developments
Table 130. KM Biologics Basic Information
Table 131. KM Biologics Inactivated Influenza Vaccine Product Overview
Table 132. KM Biologics Inactivated Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. KM Biologics Business Overview
Table 134. KM Biologics Recent Developments
Table 135. Global Inactivated Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Inactivated Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Inactivated Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Inactivated Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Inactivated Influenza Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Inactivated Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Inactivated Influenza Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Inactivated Influenza Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Inactivated Influenza Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Inactivated Influenza Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Inactivated Influenza Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Inactivated Influenza Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Inactivated Influenza Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Influenza Vaccine Product Life Cycle
Figure 13. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inactivated Influenza Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Inactivated Influenza Vaccine
Figure 19. Global Inactivated Influenza Vaccine Market PEST Analysis
Figure 20. Global Inactivated Influenza Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Influenza Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Influenza Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Influenza Vaccine by Type in 2025
Figure 29. Market Share of Inactivated Influenza Vaccine by Type (2020-2025)
Figure 30. Market Share of Inactivated Influenza Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Influenza Vaccine Market Share by Application
Figure 33. Global Inactivated Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Influenza Vaccine Sales Market Share by Application in 2025
Figure 35. Global Inactivated Influenza Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Influenza Vaccine Market Share by Application in 2025
Figure 37. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Influenza Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025)
Figure 40. North America Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 45. U.S. Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Influenza Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Influenza Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Influenza Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Influenza Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 55. Germany Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Influenza Vaccine Market Size by Region in 2024
Figure 68. China Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 82. Brazil Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Influenza Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Influenza Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Influenza Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inactivated Influenza Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inactivated Influenza Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Inactivated Influenza Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Inactivated Influenza Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Inactivated Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Inactivated Influenza Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Inactivated Influenza Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Influenza Vaccine Product Life Cycle
Figure 13. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inactivated Influenza Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Inactivated Influenza Vaccine
Figure 19. Global Inactivated Influenza Vaccine Market PEST Analysis
Figure 20. Global Inactivated Influenza Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Influenza Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Influenza Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Influenza Vaccine by Type in 2025
Figure 29. Market Share of Inactivated Influenza Vaccine by Type (2020-2025)
Figure 30. Market Share of Inactivated Influenza Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Influenza Vaccine Market Share by Application
Figure 33. Global Inactivated Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Influenza Vaccine Sales Market Share by Application in 2025
Figure 35. Global Inactivated Influenza Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Influenza Vaccine Market Share by Application in 2025
Figure 37. Global Inactivated Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Influenza Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Influenza Vaccine Market Size by Region (2020-2025)
Figure 40. North America Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 45. U.S. Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Influenza Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Influenza Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Influenza Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Influenza Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 55. Germany Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Influenza Vaccine Market Size by Region in 2024
Figure 68. China Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Influenza Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Influenza Vaccine Market Size by Country in 2024
Figure 82. Brazil Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Influenza Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Influenza Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Influenza Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Influenza Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inactivated Influenza Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inactivated Influenza Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Inactivated Influenza Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Inactivated Influenza Vaccine Market Share Forecast by Application (2026-2035)
